Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Tetrapropylammonium → 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Tetrapropylammonium | HCID 9559 | — |
| 반응물 | Methyl morpholine oxide | HCID 82029 | — |
| 반응물 | 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-OL | HCID 21897744 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-one | HCID 66915348 | — |
반응 단계
1-[3-(Propan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-4-ol (0.5 g) is dissolved in dichloromethane (75 mL) and 4 A molecular sieves (4 g) are added followed by N-methylmorpholine-N-oxide (1.52 g) and tetrapropylammonium perrhutenate (0.018 g) and the mixture is stirred at room temperature for 1 h. The reaction is then filtered through celite and the mother liquor washed with water (2×50 mL). The water layers are then combined and back extracted with dichloroemthane (100 mL). The dichloromethane layers are combined, dried over Na2SO4, filtered and concentrated to give the title compound. LC (method 20): tR=1.67 min; Mass spectrum (APCI): m/z=210 [M+H]+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08921398B2 |
| 출처 데이터셋 | uspto-grants-2014_12 |
| ORD ID | ord-38fbc51127124e7badac6fcceb6e2ec6 |
| 출처 메모 | uspto-grants-2014_12 |